Empired selected as key sub-contractor to NEC Consortium

Published 09-MAR-2017 11:34 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Shares in IT services group, Empired (ASX: EPD) spiked nearly 10% on Tuesday after the company announced that it had been selected by NEC Australia as a key sub-contractor for an initial five-year period with an option to extend for a further five years.

It should be noted share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

The nature of the work will relate to NEC Australia’s participation in the development of cloud-based ICT infrastructure as a service technology development being undertaken by the Western Australian government.

NEC Australia was selected as one of three prime contractors to provide infrastructure as a service under the GovNext-ICT contract to the whole of the W.A. government.

While the estimated spend in relation to the contract is $15 million, EPD expects considerable upside to this based on government uptake and the provision of additional services within the scope of the contract.

More specifically, EPD will have an exclusive role within the scope of the contract to provide the core collaboration functions in a cloud environment across the whole of the Western Australian government.

This role is exclusive to the NEC Consortium, and EPD’s role within the consortium is also exclusive and delivers a centralised directory services, Centralised Identity service and Certificate Authority.

This service will be provided on a per user consumption based pricing model with all users that elect to use the Western Australian government platform provided with the service. This has the potential to scale beyond 140,000 Western Australian government users based on agency take-up of the new GovNext-ICT platform.

This is further endorsement of EPD’s expertise in delivering enterprise class IT services and solutions. Furthermore, it aligns the company with high profile contractors that service the large corporate and government sectors.

While the announcement drew a significant share price rerating on Tuesday, there could be more upside to come given that EPD’s consensus 12 month price target is 70 cents, implying a 40% premium to the company’s current trading range.

Analysts at Bell Potter have a buy recommendation on the stock, and they expect the net profit to increase from $4.2 million in fiscal 2017 to $7 million in fiscal 2018, representing earnings per share of 5.6 cents.

This implies a PE multiple of 8.7 relative to Tuesday’s closing price, a substantial discount to the industry average PE multiple of 21.

Of course, broker projections and price targets are only estimates and may not be met, seek professional financial advice for more information about the stock.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X